logo-loader
viewAlgernon Pharmaceuticals Inc.

Algernon Pharmaceuticals receives ethics approval as they begin clinical trials for Ifenprodil

Algernon Pharmaceuticals Inc. (CSE: AGN-OTCQB: AGNPF) CEO Christopher Moreau joined Steve Darling to announce the company has received ethics approval from a central institutional review board for U.S. study sites for its multinational Phase 2b/3 human study of Ifenprodil for COVID-19.

Moreau explains what that means going forward and he also updated the situation in South Korea and the good news from that country when it comes to the coronavirus.

Quick facts: Algernon Pharmaceuticals Inc.

Price: 0.26 CAD

CSE:AGN
Market: CSE
Market Cap: $23.41 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Steppe Gold sees very large investment from mining legend Eric Sprott

Steppe Gold (TSX: STGO) Executive Vice President Aneel Waraich joined Steve Darling from Proactive Vancouver with news the company has had a large investment from a very big name in the mining industry. Waraich telling Proactive about having Eric Sprott as an investor and also updated the...

14 minutes ago

2 min read